| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |